LIU Jinna. Value of minimum inhibitory concentration method of microliquid culture medium versus Roche's proportional method in drug susceptibility test of mycobacterium tuberculosis[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 28-30,40. DOI: 10.7619/jcmp.202017007
Citation: LIU Jinna. Value of minimum inhibitory concentration method of microliquid culture medium versus Roche's proportional method in drug susceptibility test of mycobacterium tuberculosis[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 28-30,40. DOI: 10.7619/jcmp.202017007

Value of minimum inhibitory concentration method of microliquid culture medium versus Roche's proportional method in drug susceptibility test of mycobacterium tuberculosis

More Information
  • Received Date: May 27, 2020
  • Available Online: September 29, 2020
  • Objective To compare clinical value of the minimum inhibitory concentration(MIC)of microliquid culture medium and Roche's proportional method in the drug sensitivity test of mycobacterium tuberculosis. Methods A total of 100 mycobacterium tuberculosis strains samples provided by National Tuberculosis Laboratory of Liaoning Province were selected. The drug sensitivities of mycobacterium tuberculosis were tested by MIC and Roche's proportional method of microliquid culture medium. Results There were no significant differences in sensitivity of mycobacterium tuberculosis to drugs of ethambutol, dikanamycin, rifampicin, isoniazid, ofloxacin, and capreomycin detected by MIC method and Roche's proportional method(P>0.05). Conclusion The proportional method and MIC method have good consistency in the detection of drug sensitivity of mycobacterium tuberculosis, and has rapid detection and is economical. Therefore, they can provide theoretical basis for clinical treatmentof tuberculosis.
  • 王为娜, 龙波, 高文凤, 等. 微量MIC法和罗氏比例法对结核分枝杆菌药敏检测比对分析[J]. 寄生虫病与感染性疾病, 2019, 17(1): 52-54.
    单永梅, 王伟炳, 王建美. DNA微阵列芯片法检测耐药结核分枝杆菌的临床应用价值研究[J]. 中国防痨杂志, 2018, 40(10): 1083-1088.
    江渊, 李静, 张阳奕, 等. 细菌超声分散计数仪在结核分枝杆菌药物敏感性试验中的应用价值[J]. 中华结核和呼吸杂志, 2017, 40(4): 289-293.
    吴碧彤, 邝浩斌, 刘志辉, 等. 标准耐多药结核病化疗方案中是否对吡嗪酰胺耐药的疗效对比研究[J]. 中国防痨杂志, 2019, 41(4): 447-451.
    赵薇, 刘思洁, 李可维, 等. 894株结核分枝杆菌对一线抗结核药物的耐药情况分析[J]. 中国防痨杂志, 2019, 41(3): 364-368.
    孙京涛, 孙丽娜. 实时荧光定量PCR法分析结核分枝杆菌对异烟肼耐药的分析[J]. 临床肺科杂志, 2016, 21(9): 1650-1652

    , 1657.
    刘艳. 耐药肺结核患者结核分枝杆菌菌型分布及耐药研究[J]. 安徽医学, 2016, 37(3): 327-329.
    郭明日, 李妍, 周洪经. 微阵列芯片技术在结核分枝杆菌耐药性检测中的应用[J]. 中国热带医学, 2019, 19(9): 829-832

    , 855.
    西尔扎提·阿布力克木, 王小平, 卡木然尼·罗特布拉. 355株结核分枝杆菌药物敏感性试验的结果分析[J]. 中国防痨杂志, 2017, 39(12): 1359-1361.
    孙战强. 两种组合显色系统用于分枝杆菌快速药物敏感性试验的性能研究[J]. 中国防痨杂志, 2018, 40(7): 736-743.
    蔡杏珊, 刘燕文, 张院良, 等. 细菌超声分散计数仪在分枝杆菌药物敏感性试验中的应用价值[J]. 中国防痨杂志, 2016, 38(11): 963-967.
    刘建侠. Xpert MTB/RIF技术在基层定点医院肺结核病诊断中的应用价值[J]. 中国实验诊断学, 2016, 20(6): 928-930.
    李妍, 张天华, 鲜小萍, 等. 利用Xpert MTB/RIF检测结核分枝杆菌及利福平耐药性的研究[J]. 临床肺科杂志, 2016, 21(10): 1762-1765.
    万智敏. 结核分枝杆菌rpoB、katG和inhA基因突变株体外最小抑菌浓度的研究[D]. 衡阳: 南华大学, 2017.
    胡春梅, 郭晶, 严虹, 等. 荧光定量PCR探针熔解曲线法在结核分枝杆菌耐药基因检测中的应用[J]. 中国防痨杂志, 2016, 38(1): 38-41.
    舒丽红, 丁显平. 基因芯片方法检测耐异烟肼结核分枝杆菌准确性的Meta分析[J]. 检验医学与临床, 2016, 13(15): 2121-2125.
    王慧, 齐鹏, 刘昕, 等. 微量MIC法和罗氏比例法对结核分枝杆菌药敏检测比对及一致性观察分析[J]. 中国实验诊断学, 2019, 23(11): 1990-1991.
  • Related Articles

    [1]LI Xiaoqiong, WANG Ya, DONG Linjie, ZHANG Yifan, LUO Yao. Analysis of the confirmation results of human immunodeficiency virus antibody preliminary screening positive samples and investigation of rationality of gray zone for detecting antibody signal-to-cutoff ratio value by chemiluminescence method[J]. Journal of Clinical Medicine in Practice, 2024, 28(21): 48-52. DOI: 10.7619/jcmp.20242926
    [2]SONG Xiaoyu, SHANG Zhengling, FENG Qinying, HUANG Shan, ZHOU Xinzhong, GE Zhangwen. Correlation between clinical staging of human immunodeficiency virus infection and specific antibody immunoblot bands[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 40-43, 55. DOI: 10.7619/jcmp.20241670
    [3]JIN Xin, PENG Rui, GAO Lingling, ZHOU Wenjie. Research progress on mechanism of mother-to-child transmission of hepatitis B virus and blocking strategies[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 140-144. DOI: 10.7619/jcmp.20232552
    [4]DU Pingping, LI Fang. Differential analysis of human immunodeficiency virus-related antibody detected by enzyme linked immunosorbent assay and western blot[J]. Journal of Clinical Medicine in Practice, 2020, 24(13): 13-15,19. DOI: 10.7619/jcmp.202013004
    [5]ZHANG Lijuan. Effect of hepatitis B virus infection on perinatal maternal and child conditions in patients with intra-hepatic cholestasis of pregnancy[J]. Journal of Clinical Medicine in Practice, 2016, (11): 80-82. DOI: 10.7619/jcmp.201611023
    [6]WANG Chunying, LIU Chengyong, ZHOU Dongqing, WANG Ji, YANG Qingsong. Dynamic observation on hepatitis B virus cccDNA in liver tissue and serological markers changes in the process of antiviral therapy[J]. Journal of Clinical Medicine in Practice, 2015, (7): 44-46,56. DOI: 10.7619/jcmp.201507012
    [7]WEI Liangzhi, GUO Junfang, LI Nan, SI Yadong, YANG Yingying. Study on the mutual influence of human immunodeficiency virus and hepatitis C virus infections[J]. Journal of Clinical Medicine in Practice, 2014, (19): 45-47. DOI: 10.7619/jcmp.201419014
    [8]DING Gangqiang, KANG Yi, LIU Junping, ZENG Yanli, HOU Huanrong, WEI Junfeng, SHANG Jia. Correlation between adiponectin and liver fibrosis in patients with chronic hepatitis B virus infection[J]. Journal of Clinical Medicine in Practice, 2014, (15): 145-147. DOI: 10.7619/jcmp.201415050
    [9]JIANG Ziwei, ZHAO Hong. Studies on effect of CD4+CD25+Foxp3+regulatory T cells in chronic hepatitis B virus infection[J]. Journal of Clinical Medicine in Practice, 2013, (21): 33-35. DOI: 10.7619/jcmp.201321009
    [10]LI Yanwu, LI Zhuocheng. Analysis of 356 patients with hepatitis B virus genotyping and lamivudine treatment due to resistant mutants change[J]. Journal of Clinical Medicine in Practice, 2013, (13): 27-29. DOI: 10.7619/jcmp.201313009
  • Cited by

    Periodical cited type(9)

    1. 马雪萍,王晓丽,阿里木江·司马义,徐桂萍. 腹股沟上髂筋膜阻滞复合全身麻醉对高龄髋关节置换患者术后谵妄发生的影响. 新疆医学. 2022(02): 131-134 .
    2. 张宏,李淑萍. 老年患者髋关节置换术后谵妄的发生现状及其相关影响因素分析. 长春中医药大学学报. 2022(10): 1155-1159 .
    3. 刘贵政,郑婷婷,杜斌. 老年髋部骨折患者术后谵妄发生现况及危险因素研究. 贵州医药. 2022(09): 1405-1406 .
    4. 王秀环,鲍乐乐,马漪洁,陈宁宁. 不同麻醉方法对老年髋关节置换患者术后谵妄发生的影响. 广州医科大学学报. 2021(02): 40-44 .
    5. 刘丹,杨万翔. 人文关怀护理对人工髋关节置换术后谵妄患者临床症状的影响. 中国当代医药. 2021(25): 270-272+276 .
    6. 陈立红,徐芙蓉,叶洁玉,许华亮. 高龄骨科髋关节置换术后患者发生谵妄的危险因素分析. 现代医学与健康研究电子杂志. 2021(23): 115-118 .
    7. 毛俊岚. 高龄患者髋关节置换术后谵妄1例的护理. 基层医学论坛. 2020(03): 420-421 .
    8. 欧玉琼,吴建颖,周嫦娥. 以临床路径为指导的谵妄管理对老年股骨头置换术后患者的影响. 护理实践与研究. 2020(02): 86-88 .
    9. 姜红卫. 骨科老年患者髋关节术后谵妄发生原因及疼痛干预护理进展. 系统医学. 2020(13): 196-198 .

    Other cited types(1)

Catalog

    Article views (399) PDF downloads (17) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return